| Title | Johnson & Johnson to Become the First U.S. Drugmaker to List Drug Prices in TV Commercials | |
| Date | Saturday February 09 2019, @07:01AM | |
| Author | mrpg | |
| Topic | ||
| from the good dept. | ||
Ahead of potential regulation, Johnson & Johnson will include the list and potential out-of-pocket prices of the drugs it sells in television commercials, beginning with Xarelto (rivaroxaban):
Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald Trump for price transparency of drugs advertised directly to consumers on TV.
The healthcare conglomerate said it will include both the list price of a product - the price before any rebates or discounts to insurers or pharmacy benefit managers - as well as potential out-of-pocket costs that patients will pay.
The move, announced in a statement on J&J's website, won swift praise from U.S. Health and Human Services Secretary Alex Azar. Last May, Azar's office released a blueprint for reducing the cost of drug prices, which included a proposal to require disclosure of list prices in TV ads for drugs.
[...] Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee, on Monday invited executives from seven pharmaceutical companies, including J&J, to testify at a Feb. 26 hearing on rising drug prices.
Also at MarketWatch.
| Links |
printed from SoylentNews, Johnson & Johnson to Become the First U.S. Drugmaker to List Drug Prices in TV Commercials on 2026-01-25 09:48:45